Inventor · disambiguated record
Henry J. Smith
Also filed as: SMITH HENRY · SMITH HENRY J · SMITH HENRY JOHN
11 granted patents·38 pending applications·248 citations·filing 1990–2024
89Inventor score
Top patents by PatentIndex Score
49 records- 0191US5018450ALuminescent paintball for marking nighttime impactsSMITH HENRY J·Filed 1990·Granted May 28, 1991·127 cites·2 claims
- 0286US10076600B2Targeted apheresis for the treatment of rheumatoid arthritis and immune disordersSMITH HENRY J·Filed 2015·Granted Sep 18, 2018·3 cites·20 claims
- 0385US5001880AMethod for producing luminescent paintballsSMITH HENRY J·Filed 1990·Granted Mar 26, 1991·77 cites·1 claims
- 0477US7659107B2Rapid test for glycated albuminEPINEX DIAGNOSTICS INC·Filed 2004·Granted Feb 9, 2010·17 cites·16 claims
- 0572US7799327B2Autoantibodies utilized as carrier agents for pharmaceutical compounds used in cancer treatmentSMITH HENRY JOHN·Filed 2003·Granted Sep 21, 2010·4 cites·18 claims
- 0671US9128085B2Rapid test for glycated albumin in bloodSMITH HENRY JOHN·Filed 2009·Granted Sep 8, 2015·3 cites·11 claims
- 0770US2010086585A1Antinuclear antibody utilized as a targeting agent for pharmaceutical compounds used in the treatment of cancer and other diseasesSMITH HENRY JOHN·Filed 2009·Application pending·0 cites
- 0864US8979787B2Treatment of pre-eclampsia using targeted apheresisSMITH HENRY JOHN·Filed 2012·Granted Mar 17, 2015·3 cites·7 claims
- 0962US2025235594A1Targeted apheresis to treat inflammationSMITH HENRY J·Filed 2024·Application pending·0 cites
- 1059US2009041837A1Aptamers utilized as targeting agents for pharmaceutical compounds used in the treatment of cancer and other diseasesSMITH HENRY JOHN·Filed 2008·Application pending·0 cites
- 1159US2013330402A1Antinuclear antibody utilized as a targeting agent for pharmaceutical compounds used in the treatment of cancer and other diseasesSMITH HENRY J·Filed 2013·Application pending·0 cites
- 1256US2013039973A1Viral Immunogenic CompositionsSMITH HENRY J·Filed 2012·Application pending·0 cites
- 1355US12458595B2Thermally stabilized nanoemulsionSMITH HENRY J·Filed 2018·Granted Nov 4, 2025·0 cites·6 claims
- 1455US11806459B2Targeted apheresis to treat preeclampsiaSMITH HENRY J·Filed 2021·Granted Nov 7, 2023·0 cites·11 claims
- 1555US2010151488A1Rapid Test for Glycated AlbuminEPINEX DIAGNOSTICS INC·Filed 2009·Application pending·0 cites
- 1655US2006018829A1Cellular receptors utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatmentSMITH HENRY J·Filed 2004·Application pending·0 cites
- 1754US11590078B2Viral immunogenic compositionsSMITH HENRY J·Filed 2015·Granted Feb 28, 2023·0 cites·2 claims
- 1854US2009042237A1Aptamer based point-of-care test for glycated albuminSMITH HENRY JOHN·Filed 2008·Application pending·0 cites
- 1954US2012231066A1Multi-drug liposomes to treat tumorsSMITH HENRY JOHN·Filed 2012·Application pending·0 cites
- 2054US2014170766A1Aptamer Based Point-of-Care Test for Glycated AlbuminEPINEX DIAGNOSTICS INC·Filed 2013·Application pending·0 cites
- 2153US2022280631A1Viral pandemic vaccineSMITH HENRY J·Filed 2021·Application pending·0 cites
- 2252US2004146514A1Cancer therapy using multiple antibodies from different species directed against the tumor3Filed 2004·Application pending·0 cites
- 2352US2021008215A1Optimizing drug deliverySMITH HENRY J·Filed 2019·Application pending·0 cites
- 2451US2007015291A1Rapid test for glycated albumin in bloodSMITH HENRY J·Filed 2006·Application pending·0 cites
- 2551US2014186435A1Soluble tumor necrosis factor receptor (stnf-r) used as a targeting agent to treat arthritis and other diseasesSMITH HENRY J·Filed 2014·Application pending·0 cites
- 2651US2014186434A1Anti-tumor necrosis factor alpha (tnf-a) antibody used as a targeting agent to treat arthritis and other diseasesSMITH HENRY J·Filed 2014·Application pending·0 cites
- 2751US2006111295A1Cellular receptors utilized as carrier agents for pharmaceutical compounds used in the treatment of arthritis, inflammation and immune disordersSMITH HENRY J·Filed 2005·Application pending·0 cites
- 2851US2022008511A1Tumor treatment using cytokines and cancer drugsSMITH HENRY J·Filed 2020·Application pending·0 cites
- 2950US2020262903A1Treatment of age-related macular degenerationSMITH HENRY J·Filed 2019·Application pending·0 cites
- 3050US2019022005A1Multi-Drug Lipsomes to Treat TumorsSMITH HENRY J·Filed 2018·Application pending·0 cites
- 3149US2010247650A1Treatment for pre-eclampsia in pregnant women using targeted apheresisSMITH HENRY J·Filed 2009·Application pending·0 cites
- 3249US2006159680A1Targeted apherisis for the treatment of rheumatoid arthritisSMITH HENRY J·Filed 2006·Application pending·0 cites
- 3349US2012165781A1Targeted apheresis for the treatment of rheumatoid arthritisSMITH HENRY J·Filed 2012·Application pending·0 cites
- 3448US2010167306A1Rapid test for glycated albumin in salivaSMITH HENRY JOHN·Filed 2008·Application pending·0 cites
- 3548US2022008636A1Apheresis to remove interfering substancesSMITH HENRY J·Filed 2020·Application pending·0 cites
- 3647US5744095AMedical assay cassetteFiled 1995·Granted Apr 28, 1998·14 cites·10 claims
- 3747US2010298753A1Targeted apheresis for the treatment of rheumatoid arthritisSMITH HENRY J·Filed 2010·Application pending·0 cites
- 3847US2013101663A1Soluble tumor necrosis factor receptor (sTNF-R) used as a targeting agent to treat arthritis and other diseasesSMITH HENRY JOHN·Filed 2012·Application pending·0 cites
- 3947US2013115270A1Anti-interleukin-1 (IL-1) antibody used as a targeting agent to treat arthritis and other diseasesSMITH HENRY JOHN·Filed 2012·Application pending·0 cites
- 4047US2013115269A1Anti-tumor necrosis factor alpha (TNF-a) antibody used as a targeting agent to treat arthritis and other diseasesSMITH HENRY JOHN·Filed 2012·Application pending·0 cites
- 4147US2023341422A1A Home Test for Measuring Glucose Control and Kidney Function in PatientsEPINEX DIAGNOSTICS INC·Filed 2020·Application pending·0 cites
- 4246US2010098698A1Targeted apheresis for the treatment of rheumatoid arthritisSMITH HENRY J·Filed 2010·Application pending·0 cites
- 4346US2013068691A1Targeted apheresis for the treatment of rheumatoid arthritis and immune disordersSMITH HENRY JOHN·Filed 2012·Application pending·0 cites
- 4446US2015182632A1Anti-interleukin-1 (il-1) antibody used as a targeting agent to treat arthritis and other diseasesSMITH HENRY J·Filed 2015·Application pending·0 cites
- 4545US2008227210A1Home test for glycated albumin in salivaSMITH HENRY·Filed 2008·Application pending·0 cites
- 4645US2020069861A1Apheresis to reduce high blood pressure in pre-eclampsiaSMITH HENRY J·Filed 2019·Application pending·0 cites
- 4744US2018093032A1Targeted apheresis using binding agents or ligands immobilized on membranesSMITH HENRY JOHN·Filed 2017·Application pending·0 cites
- 4843US2006153835A1Treatment of pre-eclampsia in pregnant women using targeted apheresisSMITH HENRY J·Filed 2006·Application pending·0 cites
- 4942US2006270060A1Rapid test for glycated albumin in salivaSMITH HENRY J·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Henry J. Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →